⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
Pomerantz LLP Moves Forward with Class Action Lawsuit Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
NKTR
Pomerantz LLP Announces Securities Class Action Lawsuit Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
Pomerantz LLP Announces The Filing of a Class Action Litigation Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
prnewswire.com
NKTR
Pomerantz LLP Announces Securities Class Action Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NKTR
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
NKTR
Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR